Compare Biocon with FDC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs FDC - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON FDC BIOCON /
FDC
 
P/E (TTM) x 31.5 23.3 134.8% View Chart
P/BV x 3.7 4.5 83.0% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 BIOCON    FDC
EQUITY SHARE DATA
    BIOCON
Mar-19
FDC
Mar-18
BIOCON /
FDC
5-Yr Chart
Click to enlarge
High Rs707319 221.7%   
Low Rs554164 337.7%   
Sales per share (Unadj.) Rs91.961.6 149.1%  
Earnings per share (Unadj.) Rs16.79.9 168.0%  
Cash flow per share (Unadj.) Rs24.212.0 202.1%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.673.2 138.9%  
Shares outstanding (eoy) m600.00174.40 344.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x6.93.9 175.1%   
Avg P/E ratio x37.724.3 155.5%  
P/CF ratio (eoy) x26.120.2 129.2%  
Price / Book Value ratio x6.23.3 188.0%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,33042,118 898.3%   
No. of employees `0006.15.5 110.8%   
Total wages/salary Rs m11,6532,167 537.8%   
Avg. sales/employee Rs Th8,994.31,943.7 462.7%   
Avg. wages/employee Rs Th1,900.7391.7 485.2%   
Avg. net profit/employee Rs Th1,635.3313.7 521.3%   
INCOME DATA
Net Sales Rs m55,14410,751 512.9%  
Other income Rs m1,444510 283.4%   
Total revenues Rs m56,58811,260 502.5%   
Gross profit Rs m15,8832,267 700.6%  
Depreciation Rs m4,478351 1,274.3%   
Interest Rs m70914 5,064.3%   
Profit before tax Rs m12,1402,411 503.5%   
Minority Interest Rs m9-5 -187.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123671 316.3%   
Profit after tax Rs m10,0261,735 577.8%  
Gross profit margin %28.821.1 136.6%  
Effective tax rate %17.527.8 62.8%   
Net profit margin %18.216.1 112.7%  
BALANCE SHEET DATA
Current assets Rs m48,2287,213 668.7%   
Current liabilities Rs m30,3762,104 1,443.9%   
Net working cap to sales %32.447.5 68.1%  
Current ratio x1.63.4 46.3%  
Inventory Days Days6854 125.3%  
Debtors Days Days8628 308.4%  
Net fixed assets Rs m64,1306,865 934.2%   
Share capital Rs m3,000175 1,712.3%   
"Free" reserves Rs m57,98012,586 460.7%   
Net worth Rs m60,98012,761 477.9%   
Long term debt Rs m15,7666 262,766.7%   
Total assets Rs m121,92415,041 810.6%  
Interest coverage x18.1173.2 10.5%   
Debt to equity ratio x0.30 54,988.4%  
Sales to assets ratio x0.50.7 63.3%   
Return on assets %8.811.6 75.7%  
Return on equity %16.413.6 120.9%  
Return on capital %16.819.0 88.4%  
Exports to sales %28.112.3 227.8%   
Imports to sales %18.90-   
Exports (fob) Rs m15,5061,327 1,168.6%   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,5061,889 820.9%   
Fx outflow Rs m10,3990-   
Net fx Rs m5,1071,889 270.4%   
CASH FLOW
From Operations Rs m11,5461,498 770.6%  
From Investments Rs m-7,138201 -3,549.5%  
From Financial Activity Rs m-2,417-1,694 142.7%  
Net Cashflow Rs m2,10310 20,417.5%  

Share Holding

Indian Promoters % 40.4 68.9 58.6%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.7 178.7%  
FIIs % 10.7 7.5 142.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 19.0 104.7%  
Shareholders   109,995 23,730 463.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  IPCA LABS  NATCO PHARMA  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 7, 2021 (Close)

TRACK BIOCON

BIOCON - WYETH COMPARISON

COMPARE BIOCON WITH

MARKET STATS